These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 8377827

  • 21. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.
    Chew YP, Ellis M, Wilkie S, Mittnacht S.
    Oncogene; 1998 Oct 29; 17(17):2177-86. PubMed ID: 9811449
    [Abstract] [Full Text] [Related]

  • 22. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
    Zacksenhaus E, Jiang Z, Phillips RA, Gallie BL.
    EMBO J; 1996 Nov 01; 15(21):5917-27. PubMed ID: 8918469
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW, Sørensen TS, Shikama N, La Thangue NB.
    Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736
    [Abstract] [Full Text] [Related]

  • 27. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53.
    Hunt KK, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Clayman G, Hung MC.
    Cancer Res; 1997 Nov 01; 57(21):4722-6. PubMed ID: 9354430
    [Abstract] [Full Text] [Related]

  • 28. Evidence for GEAPS, novel Glial E2F1-Associated Proteins in hamster glioma cells induced by the human neurotropic polyomavirus, JCV.
    Raj GV, Ansari SA, Khalili K.
    Oncogene; 1996 Mar 21; 12(6):1279-88. PubMed ID: 8649830
    [Abstract] [Full Text] [Related]

  • 29. Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins.
    Logan TJ, Evans DL, Mercer WE, Bjornsti MA, Hall DJ.
    Cancer Res; 1995 Jul 01; 55(13):2883-91. PubMed ID: 7540951
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.
    Johnson DG, Ohtani K, Nevins JR.
    Genes Dev; 1994 Jul 01; 8(13):1514-25. PubMed ID: 7958836
    [Abstract] [Full Text] [Related]

  • 33. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression.
    Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S, Wang XF, Nevins JR.
    Proc Natl Acad Sci U S A; 1995 Jan 17; 92(2):483-7. PubMed ID: 7831315
    [Abstract] [Full Text] [Related]

  • 34. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.
    Ebelt H, Hufnagel N, Neuhaus P, Neuhaus H, Gajawada P, Simm A, Müller-Werdan U, Werdan K, Braun T.
    Circ Res; 2005 Mar 18; 96(5):509-17. PubMed ID: 15718499
    [Abstract] [Full Text] [Related]

  • 35. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis.
    Kowalik TF, DeGregori J, Schwarz JK, Nevins JR.
    J Virol; 1995 Apr 18; 69(4):2491-500. PubMed ID: 7884898
    [Abstract] [Full Text] [Related]

  • 36. Phenotypic differentiation without permanent cell-cycle arrest by skeletal myocytes with deregulated E2F-1.
    Chen G, Lee EY.
    DNA Cell Biol; 1999 Apr 18; 18(4):305-14. PubMed ID: 10235113
    [Abstract] [Full Text] [Related]

  • 37. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
    Ofir M, Hacohen D, Ginsberg D.
    Mol Cancer Res; 2011 Apr 18; 9(4):440-7. PubMed ID: 21454377
    [Abstract] [Full Text] [Related]

  • 38. Evolving intricacies and implications of E2F1 regulation.
    Mundle SD, Saberwal G.
    FASEB J; 2003 Apr 18; 17(6):569-74. PubMed ID: 12665469
    [Abstract] [Full Text] [Related]

  • 39. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes.
    DeGregori J, Kowalik T, Nevins JR.
    Mol Cell Biol; 1995 Aug 18; 15(8):4215-24. PubMed ID: 7623816
    [Abstract] [Full Text] [Related]

  • 40. The transcription factor E2F-1 is a downstream target of RB action.
    Qin XQ, Livingston DM, Ewen M, Sellers WR, Arany Z, Kaelin WG.
    Mol Cell Biol; 1995 Feb 18; 15(2):742-55. PubMed ID: 7823942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.